Simultaneous deletion of PAX5 and CDKN2A is a common event in leukemogenesis and most ALL patients with a deletion of PAX5 have a concurrent deletion of CDKN2A (Kimet al., 2009). The gene discussed is PAX5; the disease is acute lymphoblastic leukemia.